Lung Therapeutics, Inc. 4
4 · TFF Pharmaceuticals, Inc. · Filed Dec 8, 2020
Insider Transaction Report
Form 4
Lung Therapeutics, Inc.
10% Owner
Transactions
- Sale
Common Stock
2020-12-04$13.86/sh−250,000$3,465,000→ 2,950,000 total - Sale
Common Stock
2020-12-04$13.85/sh−500,000$6,925,000→ 3,500,000 total - Sale
Common Stock
2020-12-04$13.86/sh−300,000$4,158,000→ 3,200,000 total